MENU
IMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

I-MAB (IMAB) Earnings Date & Reports

I-MAB is a clinical-stage biotech company... Show more

A.I. Advisor
published Earnings

IMAB is expected to report earnings to rise 113.17% to -12 cents per share on November 29

I-MAB IMAB Stock Earnings Reports
Q3'23
Est.
$-0.13
Q4'24
Est.
$-0.06
Q3'24
Missed
by $0.04
Q2'24
Beat
by $0.22
Q1'24
Est.
$-0.22
The last earnings report on March 26 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 123.31K shares outstanding, the current market capitalization sits at 63.43M.
View a ticker or compare two or three
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
555 West Haiyang Road
Phone
+86 2160578000
Employees
318
Web
https://www.i-mabbiopharma.com